Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?

Coronavirus disease 2019 (COVID-19) is a pandemic viral disease originated in Wuhan, China, in December 2019, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The severe form of the disease is often associated with acute respiratory distress syndrome (ARDS), and most criti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gardin, Chiara, Ferroni, Letizia, Chachques, Juan Carlos, Zavan, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565764/
https://www.ncbi.nlm.nih.gov/pubmed/32858940
http://dx.doi.org/10.3390/jcm9092762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565764/
https://www.ncbi.nlm.nih.gov/pubmed/32858940
http://dx.doi.org/10.3390/jcm9092762

Ejemplares similares